Clinical Trials Become Target for Insider Trading

Clinical Trials Become Target for Insider Trading Play

Nov. 13 (Bloomberg) -- Bloomberg News' David Voreacos discusses insider trading in the health care industry. He speaks with Mark Crumpton on Bloomberg Television's "Bottom Line." (Source: Bloomberg)

  • On Air Now

    Bloomberg West Watch Now

  • Next

    Bloomberg West

(enter your email)
(enter up to 5 email addresses, separated by commas)

Max 250 characters

blog comments powered by Disqus